25
Views
22
CrossRef citations to date
0
Altmetric
Article

Prep1 Directly Regulates the Intrinsic Apoptotic Pathway by Controlling Bcl-XL Levels

, , , &
Pages 1143-1151 | Received 11 Aug 2008, Accepted 14 Dec 2008, Published online: 21 Mar 2023
 

Abstract

The Prep1 homeodomain transcription factor is essential in embryonic development. Prep1 hypomorphic mutant mouse (Prep1i/i) embryos (embryonic day 9.5) display an increased terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling reaction compared to wild-type (WT) littermates. Prep1i/i mouse embryo fibroblasts (MEFs) show an increased basal level of annexin V binding activity, reduction of the mitochondrial-membrane potential, and increased caspase 9 and 3 activation, indicating increased apoptosis. Prep1i/i MEFs also respond faster than WT MEFs to genotoxic stress, indicating increased activation of the intrinsic apoptotic pathways. We did not observe an increase in p53 or an abnormal p53 response to apoptotic stimuli. However, hypomorphic MEFs have decreased endogenous levels of antiapoptotic Bcl-XL mRNA and protein, and Bcl-x overexpression rescues the defect of Prep1i/i MEFs. Using transient transfections and chromatin immunoprecipitation, we identified the Bcl-x promoter as a novel target of Prep1. Thus, Prep1 directly controls mitochondrial homeostasis (and the apoptotic potential) by modulating Bcl-x gene expression.

SUPPLEMENTAL MATERIAL

Supplemental material for this article may be found at http://mcb.asm.org/ .

ACKNOWLEDGMENTS

We are grateful to Gerry Melino (Università di Roma Tor Vergata) for discussion and advice, Daniela Talarico (S. Raffaele Scientific Institute) and Elena Longobardi (IFOM) for critical discussions and technical help, Silvia Mori (S. Raffaele Scientific Institute) for the pBabe-Prep1 retroviral vector, and Marco Giorgio and Raluca Marcu (IFOM) for their help in JC-1 staining experiments.

This work was supported by grants from the Italian Association for Cancer Research (AIRC) (number 4/2005) Telethon and the Italian Ministry of University and Scientific Research to F.B. and from AIRC (number 63/2006) and the Istituto Superiore di Sanità to M.P.C.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.